Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
2.
Eur Respir J ; 34(1): 176-9, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19251788

ABSTRACT

The sensitivity of the Enhanced Tuberculosis Surveillance (ETS) scheme for monitoring tuberculosis in children is unknown. We used the British Paediatric Surveillance Unit (BPSU) reporting scheme to conduct a prospective observational study of tuberculosis in children aged <16 yrs in the UK. Reported cases were then matched with records from the ETS database. A total of 320 cases were reported to the BPSU between January and December 2004. We estimated that there were 557 paediatric cases in England, Wales and Northern Ireland in 2004: 222 (40%) cases reported to both BPSU and ETS, 98 (18%) reported to BPSU but not ETS and 237 (42%) reported to ETS but not BPSU. Children aged <5 yrs were significantly less likely to be reported to ETS compared with older children (p<0.01). There is substantial under-reporting of childhood tuberculosis, especially of children aged <5 yrs. ETS provides a representative picture of the demographics but may miss approximately 20% of cases. This should be taken into account when planning training and resource requirements for tuberculosis. Increased efforts are needed to ensure that all paediatric cases are reported to ETS.


Subject(s)
Tuberculosis/diagnosis , Tuberculosis/epidemiology , Adolescent , Antitubercular Agents/therapeutic use , Child , Child, Preschool , England , Health Surveys , Humans , Infant , Infant, Newborn , London , Northern Ireland , Population Surveillance/methods , Public Health Informatics/methods , Wales
3.
Arch Dis Child ; 94(4): 263-7, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19052030

ABSTRACT

AIMS: To describe the clinical features, diagnosis and management of children with tuberculosis in the United Kingdom and Republic of Ireland. METHODS: Cases of culture-confirmed and clinically diagnosed tuberculosis were reported to the British Paediatric Surveillance Unit from December 2003 to January 2005. RESULTS: 385 eligible cases were reported. Pulmonary disease was present in 154 (40%) children. Just over half (197, 51%) of children presented clinically and most of the remainder (166, 43%) at contact tracing. A probable source case was identified for 73/197 (36%) of the children presenting clinically. The majority (253, 66%) of children had a microbiological and/or histological investigation, and culture results were available for 240 (62%), of whom 102 (26%) were culture positive. Drug resistance was reported in 15 (0.4%) cases. 44% (128/292) of non-white children did not receive the recommended quadruple drug therapy. Seven children died. Only 57% (217) of children were managed by a paediatric subspecialist in respiratory or infectious diseases or a general paediatrician with a special interest in one of these areas. Fewer than five cases were reported from 119/143 (83%) respondents and 72 of 96 (75%) centres. CONCLUSIONS: Many paediatricians and centres see few children with tuberculosis. This may affect adherence to national guidelines. Managed clinical networks for children with tuberculosis may improve management and should be the standard of care.


Subject(s)
Tuberculosis , Adolescent , Antitubercular Agents/therapeutic use , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Ireland , Male , Prospective Studies , Tuberculosis/diagnosis , Tuberculosis/drug therapy , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/drug therapy , United Kingdom
6.
Ann N Y Acad Sci ; 953: 233-40, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11795417

ABSTRACT

The costs of multidrug-resistant tuberculosis (MDR TB) reach far beyond the cost of the clinical treatment of the patient. The first impact of the discovery of MDR TB in a population is the need to recognize that all TB patients have the potential of being MDR. Public health measures to prevent the spread of MDR TB, or to control or reverse the problem where spread has already occurred, can be extremely expensive to implement. At the level of the individual patient, the second-line drugs used to treat MDR TB are more expensive, and the remaining first-line drugs will have to be used for a longer time than in drug-susceptible TB. Negative-pressure units add to the costs of treatment, as does the increased nursing intensity required. The cost to the wider economy includes lost productivity and lost tax revenue to the state as well as the cost of supporting the family if the patient is the breadwinner.


Subject(s)
Tuberculosis, Multidrug-Resistant/economics , Cost of Illness , Humans , Public Health
7.
Thorax ; 55(11): 962-3, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11050268

ABSTRACT

BACKGROUND: Multidrug resistant tuberculosis (MDR TB) requires a complex drug regimen and lengthy multidisciplinary care. The financial cost of successful management of each case is potentially large. METHODS: The costs of managing nine HIV negative patients with pulmonary MDR TB were compared with 18 age group and ethnicity matched controls with fully sensitive disease. Calculations included: cost of outpatient visits and inpatient stays including negative pressure isolation; costs of drug provision and toxicity monitoring; costs of additional procedures and multidisciplinary referrals. RESULTS: The mean cost of managing a case of pulmonary MDR TB was in excess of 60,000 pounds sterling and for sensitive disease it was 6040 pounds sterling. CONCLUSIONS: Clinicians and healthcare commissioning authorities may both be underestimating the costs of managing MDR TB, and accordingly the consequences for units dealing with such cases may be serious. Funding of care for MDR TB in the UK requires strategic decisions at regional or governmental level.


Subject(s)
Delivery of Health Care/economics , Tuberculosis, Multidrug-Resistant/economics , Case-Control Studies , Health Care Costs , Health Resources/economics , Health Resources/statistics & numerical data , Humans , State Medicine , Tuberculosis, Multidrug-Resistant/therapy , United Kingdom
11.
J Infect ; 32(2): 153-4, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8708375

ABSTRACT

Multidrug-resistant Mycobacterium tuberculosis infection (MDR-TB) in those who are HIV positive has until now been largely a North American phenomenon. We report a fatal case in London.


Subject(s)
HIV Seropositivity/complications , Tuberculosis, Multidrug-Resistant/etiology , Adult , Humans , Male
14.
BMJ ; 310(6985): 967-9, 1995 Apr 15.
Article in English | MEDLINE | ID: mdl-7728031

ABSTRACT

OBJECTIVE: To examine factors responsible for the recent increase in tuberculosis in England and Wales. DESIGN: Study of the incidence of tuberculosis (a) in the 403 local authority districts in England and Wales, ranked according to Jarman score, and (b) in one deprived inner city district, according to ethnic origin and other factors. SETTING: (a) England and Wales 1980-92, and (b) the London borough of Hackney 1986-93. MAIN OUTCOME MEASURE: Age and sex adjusted rate of tuberculosis. RESULTS: In England and Wales notifications of tuberculosis increased by 12% between 1988 and 1992. The increase was 35% in the poorest 10th of the population and 13% in the next two; and in the remaining 70% there was no increase. In Hackney the increase affected traditionally high risk and low risk ethnic groups to a similar extent. In the "low risk" white and West Indian communities the incidence increased by 58% from 1986-8 (78 cases) to 1991-3 (123), whereas in residents of Indian subcontinent origin the increase was 41% (from 51 cases to 72). Tuberculosis in recently arrived immigrants--refugees (11% of the Hackney population) and Africans (6%)--accounted for less than half of the overall increase, and the proportion of such residents was much higher than in most socioeconomically deprived districts. The local increase was not due to an increase in the proportion of cases notified, to HIV infection, nor to an increase in homeless people. CONCLUSIONS: The national rise in tuberculosis affects only the poorest areas. Within one such area all residents (white and established ethnic minorities) were affected to a similar extent. The evidence indicates a major role for socioeconomic factors in the increase in tuberculosis and only a minor role for recent immigration from endemic areas.


Subject(s)
Tuberculosis/epidemiology , Asia/ethnology , Crowding , Disease Notification , England/epidemiology , Humans , Incidence , India/ethnology , Poverty Areas , Refugees , Risk Factors , Tuberculosis/ethnology , Turkey/ethnology , Wales/epidemiology , West Indies/ethnology
15.
16.
Br J Hosp Med ; 51(8): 398-401, 1994.
Article in English | MEDLINE | ID: mdl-8081576

ABSTRACT

Respiratory disease is common in pregnancy, and becoming more so: asthma, pneumonia and tuberculosis are all increasing in frequency. This review discusses these conditions and their relationship to pregnancy, as well as considering briefly some rarer diseases.


Subject(s)
Lung Diseases , Pregnancy Complications , Female , Humans , Incidence , Lung Diseases/diagnosis , Lung Diseases/epidemiology , Lung Diseases/physiopathology , Lung Diseases/therapy , Patient Care Team , Patient Education as Topic , Pregnancy , Pregnancy Complications/diagnosis , Pregnancy Complications/epidemiology , Pregnancy Complications/physiopathology , Pregnancy Complications/therapy , Pregnancy Outcome , Risk Factors
18.
Arch Dis Child ; 69(2): 229-31, 1993 Aug.
Article in English | MEDLINE | ID: mdl-8215527

ABSTRACT

Childhood tuberculosis is perceived by many as a disease of the past. Experience in a children's hospital serving a deprived population suggested that tuberculosis and other mycobacterial infections were not declining in clinical practice. Fifty three tuberculous and 11 atypical mycobacterial infections were identified between 1978 and 1992. There was no decline in tuberculosis and nine of the 11 atypical infections occurred in the last five years. Altogether 40% of cases of tuberculosis were in non-Asian children; 32% had arrived in the UK or visited family overseas in the previous year; and 38% had a history of tuberculosis contact, usually a close adult relative. Nationally, the previous decline in tuberculosis in all ages has reversed. In the local health districts in London's east end, childhood tuberculosis has also stopped declining and seems to be increasing. It is regrettable that BCG vaccination has been abolished by some districts in the UK, against current recommendations. Childhood tuberculosis is still common in the practice described here, including among children who do not fall into conventionally recognised high risk groups. Inner city dwellers and junior doctors are both highly mobile populations, adding to the risk that paediatricians, particularly those in training, may encounter tuberculosis with little or no previous experience of the condition.


Subject(s)
Hospitals, Pediatric , Mycobacterium Infections/epidemiology , Tuberculosis/epidemiology , Urban Population , Adolescent , BCG Vaccine , Child , Child, Preschool , Female , Humans , Infant , London/epidemiology , Male , Mycobacterium Infections, Nontuberculous/epidemiology , Travel , Tuberculosis/prevention & control
19.
Thorax ; 48(7): 708-13, 1993 Jul.
Article in English | MEDLINE | ID: mdl-8153918

ABSTRACT

BACKGROUND: Prescription and use of long term oxygen treatment were audited in a large group of patients after more than five years of use of the guidelines for its prescription. METHODS: Patients with a concentrator were interviewed at home with a structured questionnaire in three family health service authorities in East London. Stable oxygen saturation (SaO2) breathing air and oxygen, forced expiratory volume in one second (FEV1) and current and previous dated concentrator meter readings were recorded. A further questionnaire was sent to each patient's general practitioner. Hospital case notes of patients who did not meet the criteria for long term oxygen treatment at reassessment were reviewed. RESULTS: A total of 176 patients were studied; 84% had chronic obstructive lung disease and 19% admitted to continued smoking; 140 patients had seen a respiratory physician but results of respiratory assessment were available to their general practitioner in fewer than 54 cases. FEV1 was < 1.5 1 in 158 patients but in 67 SaO2 was less than 91% breathing air, mainly in patients with chronic obstructive lung disease who had been inadequately assessed. Daily oxygen was prescribed for a median of 15 (range 4-24) hours and measured daily use was 15 (0-24) hours; 74% of patients used more than 12 hours. Only 35 patients had problems with oxygen treatment, but 29 had an undercorrected SaO2 of less than 92% when using their concentrator. CONCLUSIONS: Guidelines for prescription of long term oxygen treatment are largely followed and most patients complied with treatment. Increased communication about respiratory state is required between hospital doctors and general practitioners. Patients need regular reassessments to ensure that hypoxaemia is corrected and that oxygen is appropriately prescribed.


Subject(s)
Oxygen Inhalation Therapy , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Forced Expiratory Volume , Home Care Services , Humans , Lung Diseases, Obstructive/blood , Lung Diseases, Obstructive/physiopathology , Lung Diseases, Obstructive/therapy , Male , Middle Aged , Oxygen/blood , Patient Compliance , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...